<DOC>
	<DOCNO>NCT01702142</DOCNO>
	<brief_summary>A team researcher University Wisconsin-Madison College Engineering Oregon Health &amp; Science University test whether clinician training use organizational change strategy sufficient disseminate evidence-based practice ( EBP ) , change organizational system payer policy result great EBP use . Demonstrating role payment policy driver adoption evidence-based practice could provide contribution dissemination implementation science . This study employ intervention develop Robert Wood Johnson Foundation-funded Advancing Recovery ( AR ) program . In AR , payer/treatment organization partnership 12 state collaborate remove systemic barrier adoption EBPs medication-assisted treatment substance abuse disorder . The result `` AR Framework '' payer organizational change strategy test ability increase use addiction medication buprenorphine compare organizational change strategy alone . Buprenorphine EBP treat people addict heroin opioid-based pain medication non-medical use . Buprenorphine experience low adoption rate standard part addiction treatment . In Ohio , location study , death due accidental overdoses opioids increase 304 % past decade surpass auto accident lead cause accidental death 2006 . Ohio select study public health significance opioid abuse county Ohio act stand-alone payer , offer 48 unique eligible payer environment . This trial develop deeper understand role payer treatment organization play implement disseminate EBPs focus public health issue rise opioid abuse .</brief_summary>
	<brief_title>To Test Payer/Treatment Agency Intervention Increase Use Buprenorphine</brief_title>
	<detailed_description>Buprenorphine ( EBP ) use data collect November , 2012 May , 2016 administrative database locate state Ohio . Participants follow duration Buprenorphine use average 5-7 month . Organizational Payer data collect January , 2013 January , 2015 . The data study analyze report January 2015 February 2017 .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Treatment agency great 75 admission per year</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Addiction Treatment</keyword>
</DOC>